JAK2 and myeloproliferative neoplasm: In cases where the JAK2 V617F mutation is not detected, further genetic investigations for MPN should be considered, including other driver mutations, such as CALR mutations, as well as conducting a comprehensive screening for other MPN-associated mutations using NGS [85].